The University of Chicago Header Logo

Nelarabine in the treatment of refractory T-cell malignant diseases.

Nelarabine in the treatment of refractory T-cell malignant diseases. Expert Opin Pharmacother. 2006 Sep; 7(13):1791-9.

View in: PubMed